Publications by authors named "Feda Azab"

Claim this Profile
I
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma.
Jennifer Sun, Stefan Corradini, Feda Azab, Monica Shokeen, Barbara Muz, Abdel Kareem Azab

Leukemia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia.
Feda Azab, Abdel Kareem Azab, Patricia Maiso, Teresa Calimeri, Ludmila Flores

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia.
Aldo M Roccaro, Antonio Sacco, Xiaojing Jia, Ranjit Banwait, Patricia Maiso, Feda Azab, Abdel Kareem Azab

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma.
Kinan Alhallak, Amanda Jeske, Pilar de la Puente, Jennifer Sun, Mark Fiala, Feda Azab, Abdel Kareem Azab

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4-targeted PET imaging using Cu-AMD3100 for detection of Waldenström Macroglobulinemia.
Barbara Muz, Nilantha Bandara, Cedric Mpoy, Jennifer Sun, Kinan Alhallak, Feda Azab, Abdel Kareem Azab

Cancer Biol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma.
Cinzia Federico, Kinan Alhallak, Jennifer Sun, Kathleen Duncan, Feda Azab, Abdel Kareem Azab

Nat Commun· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy.
Barbara Muz, Feda Azab, Mark Fiala, Justin King, Daniel Kohnen, Abdel Kareem Azab

Blood Cancer J· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma.
Barbara Muz, Maurizio Buggio, Feda Azab, Pilar de la Puente, Mark Fiala, Abdel Kareem Azab

Haematologica· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance.
Barbara Muz, Hubert D Kusdono, Feda Azab, Pilar de la Puente, Cinzia Federico, Abdel Kareem Azab

Leuk Lymphoma· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma.
Barbara Muz, Feda Azab, Pilar de la Puente, Yosef Landesman, Abdel Kareem Azab

Transl Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib.
Barbara Muz, Feda Azab, Pilar de la Puente, Scott Rollins, Richard Alvarez, Abdel Kareem Azab

Biomed Res Int· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma.
Pilar de la Puente, Feda Azab, Barbara Muz, Micah Luderer, Jack Arbiser, Abdel Kareem Azab

Leuk Lymphoma· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma.
Barbara Muz, Pilar de la Puente, Feda Azab, Micah John Luderer, Justin King, Abdel Kareem Azab

Br J Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.
Pilar de la Puente, Barbara Muz, Rebecca C Gilson, Feda Azab, Micah Luderer, Abdel Kareem Azab

Biomaterials· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy.
Barbara Muz, Pilar de la Puente, Feda Azab, Abdel Kareem Azab

Hypoxia (Auckl)· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.
Barbara Muz, Pilar de la Puente, Feda Azab, Irene M Ghobrial, Abdel Kareem Azab

Mol Cancer Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.
Ilyas Sahin, Feda Azab, Yuji Mishima, Michele Moschetta, Brian Tsang, Abdel Kareem Azab

Am J Hematol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of hypoxia and exploitation of the hypoxic environment in hematologic malignancies.
Barbara Muz, Pilar de la Puente, Feda Azab, Micah Luderer, Abdel Kareem Azab

Mol Cancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecularly targeted therapies in multiple myeloma.
Pilar de la Puente, Barbara Muz, Feda Azab, Micah Luderer, Abdel Kareem Azab

Leuk Res Treatment· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.
Feda Azab, Shireen Vali, Joseph Abraham, Nicholas Potter, Barbara Muz, Abdel Kareem Azab

Br J Haematol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma.
Yang Liu, Phong Quang, Esteban Braggio, Hai Ngo, Gayane Badalian-Very, Abdel Kareem Azab, Feda Azab

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell trafficking of endothelial progenitor cells in tumor progression.
Pilar de la Puente, Barbara Muz, Feda Azab, Abdel Kareem Azab

Clin Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.
Aldo M Roccaro, Antonio Sacco, Patricia Maiso, Abdel Kareem Azab, Yu-Tzu Tai, Feda Azab

J Clin Invest· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia.
Irene M Ghobrial, Federico Campigotto, Timothy J Murphy, Erica N Boswell, Ranjit Banwait, Feda Azab

Blood· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia.
Aldo M Roccaro, Antonio Sacco, Xiaojing Jia, Ranjit Banwait, Patricia Maiso, Feda Azab, Abdel Kareem Azab

Clin Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis